Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine)

Cancer Treat Rev. 1993 Jan;19(1):45-55. doi: 10.1016/0305-7372(93)90026-n.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / pharmacology*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / pharmacology
  • Deoxycytidine / therapeutic use
  • Drug Evaluation
  • Drug Evaluation, Preclinical
  • Gemcitabine
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms, Experimental / drug therapy

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Deoxycytidine
  • Gemcitabine